|
|
Office Locations:
|
One Gateway Center, Suite 407
Newton, MA 02458
Phone: 617-332-3408
Fax: 617-332-8463
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Mediphase Venture Partners (MVP) focuses on early stage companies in the areas of biopharmaceutical technology and life sciences information. The firm looks in particular for companies that can achieve rapid product development and customer revenue, which are efficient in use of capital, and which have strong intellectual property positions. Mediphase will also review opportunities in enabling technologies for drug discovery, and will make occasional investments in other areas of life sciences/health care. The fund makes investments of approximately $4 million to $8 million per company.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
